[在日本患者中对葡萄糖酶的II期研究,在高剂量甲醇治疗后甲醇清除延迟]
Keiko Okada1, Chitose Ogawa2, Rishu Kayatani1
1Department of Pediatrics Hematology/Oncology, Osaka City General Hospital.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|December 7, 2025
概括
葡萄糖酶有效降低了延迟排泄的日本患者的高血甲醇度. 该疗法表现出良好的安全性,类似于之前的研究,支持其临床使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 高剂量甲状腺素 (HD-MTX) 治疗对于治疗各种癌症至关重要.
- 延迟的甲状腺脱可以导致严重的毒性.
- 管理延迟MTX清除的有效方法是必不可少的.
研究的目的:
- 评估葡萄糖酶在日本患者的疗效和安全性,这些患者在HD-MTX后经历了延迟的甲状腺素排泄.
- 在临床接近的条件下,评估葡萄糖酶在管理甲状腺素毒性的作用.
主要方法:
- 进行了一项多中心,单臂,开放的II期临床研究.
- 根据延迟MTX排泄的包装插入标准,Glucarpidase被给予八名日本患者.
- 在葡萄糖皮达酶给药后,继续对HD-MTX进行支持性治疗.
主要成果:
- 所有患者在第一个葡萄糖皮达酶剂剂后48小时内,血甲状腺酸盐 (MTX) 度至少降低了90%.
- 87.5%的患者达到1μmol/l以下的血MTX水平.
- 25.0%的患者经历了3级以上的不良事件,没有与葡萄糖酶有因果关系.
结论:
- 葡萄糖酶在研究人口中显著有效降低血MTX度.
- 葡萄糖酶的安全性与之前的研究结果一致,表明它适合临床实践.
- 这些结果支持使用葡萄糖酶作为一种有价值的药物来管理在临床环境中延迟的MTX消除.
相关概念视频
Phase II Reactions: Glucuronidation
1.6K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.6K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
784
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
784
Phase II Reactions: Methylation Reactions
657
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
657
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
413
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
413
Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
862
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
862


